These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

602 related articles for article (PubMed ID: 16596586)

  • 1. Nanoparticles of poly(D,L-lactide)/methoxy poly(ethylene glycol)-poly(D,L-lactide) blends for controlled release of paclitaxel.
    Dong Y; Feng SS
    J Biomed Mater Res A; 2006 Jul; 78(1):12-9. PubMed ID: 16596586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanoparticles of poly(lactide)/vitamin E TPGS copolymer for cancer chemotherapy: synthesis, formulation, characterization and in vitro drug release.
    Zhang Z; Feng SS
    Biomaterials; 2006 Jan; 27(2):262-70. PubMed ID: 16024075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methoxy poly(ethylene glycol)-poly(lactide) (MPEG-PLA) nanoparticles for controlled delivery of anticancer drugs.
    Dong Y; Feng SS
    Biomaterials; 2004 Jun; 25(14):2843-9. PubMed ID: 14962562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Graphene oxide stabilized by PLA-PEG copolymers for the controlled delivery of paclitaxel.
    Angelopoulou A; Voulgari E; Diamanti EK; Gournis D; Avgoustakis K
    Eur J Pharm Biopharm; 2015 Jun; 93():18-26. PubMed ID: 25817600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The drug encapsulation efficiency, in vitro drug release, cellular uptake and cytotoxicity of paclitaxel-loaded poly(lactide)-tocopheryl polyethylene glycol succinate nanoparticles.
    Zhang Z; Feng SS
    Biomaterials; 2006 Jul; 27(21):4025-33. PubMed ID: 16564085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microporous structure and drug release kinetics of polymeric nanoparticles.
    Sant S; Thommes M; Hildgen P
    Langmuir; 2008 Jan; 24(1):280-7. PubMed ID: 18052222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro and in vivo evaluation of methoxy polyethylene glycol-polylactide (MPEG-PLA) nanoparticles for small-molecule drug chemotherapy.
    Dong Y; Feng SS
    Biomaterials; 2007 Oct; 28(28):4154-60. PubMed ID: 17576004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deoxycholic acid-modified chitooligosaccharide/mPEG-PDLLA mixed micelles loaded with paclitaxel for enhanced antitumor efficacy.
    Jiang C; Wang H; Zhang X; Sun Z; Wang F; Cheng J; Xie H; Yu B; Zhou L
    Int J Pharm; 2014 Nov; 475(1-2):60-8. PubMed ID: 25152167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro investigation on poly(lactide)-Tween 80 copolymer nanoparticles fabricated by dialysis method for chemotherapy.
    Zhang Z; Feng SS
    Biomacromolecules; 2006 Apr; 7(4):1139-46. PubMed ID: 16602731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Folate-conjugated amphiphilic star-shaped block copolymers as targeted nanocarriers.
    Zhu J; Zhou Z; Yang C; Kong D; Wan Y; Wang Z
    J Biomed Mater Res A; 2011 Jun; 97(4):498-508. PubMed ID: 21509931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of polyethylene glycol (PEG) chain organization on the physicochemical properties of poly(D, L-lactide) (PLA) based nanoparticles.
    Essa S; Rabanel JM; Hildgen P
    Eur J Pharm Biopharm; 2010 Jun; 75(2):96-106. PubMed ID: 20211727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ionically fixed polymeric nanoparticles as a novel drug carrier.
    Lee SW; Chang DH; Shim MS; Kim BO; Kim SO; Seo MH
    Pharm Res; 2007 Aug; 24(8):1508-16. PubMed ID: 17380262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peptide-conjugated biodegradable nanoparticles as a carrier to target paclitaxel to tumor neovasculature.
    Yu DH; Lu Q; Xie J; Fang C; Chen HZ
    Biomaterials; 2010 Mar; 31(8):2278-92. PubMed ID: 20053444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Poly(ester anhydride)/mPEG amphiphilic block co-polymer nanoparticles as delivery devices for paclitaxel.
    Liang Y; Xiao L; Li Y; Zhai Y; Xie C; Deng L; Dong A
    J Biomater Sci Polym Ed; 2011; 22(4-6):701-15. PubMed ID: 20566053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted delivery of paclitaxel using folate-decorated poly(lactide)-vitamin E TPGS nanoparticles.
    Pan J; Feng SS
    Biomaterials; 2008 Jun; 29(17):2663-72. PubMed ID: 18396333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and characterization of the paclitaxel/MPEG-PLA block copolymer conjugate.
    Zhang X; Li Y; Chen X; Wang X; Xu X; Liang Q; Hu J; Jing X
    Biomaterials; 2005 May; 26(14):2121-8. PubMed ID: 15576187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of aqueous solubility of grafted moiety on the physicochemical properties of poly(d,l-lactide) (PLA) based nanoparticles.
    Essa S; Rabanel JM; Hildgen P
    Int J Pharm; 2010 Mar; 388(1-2):263-73. PubMed ID: 20060450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biodegradable polymersomes as carriers and release systems for paclitaxel using Oregon Green® 488 labeled paclitaxel as a model compound.
    Lee JS; Feijen J
    J Control Release; 2012 Mar; 158(2):312-8. PubMed ID: 22063005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of cationic nanoparticles of biodegradable copolymers as siRNA delivery system for hepatitis B treatment.
    Wang J; Feng SS; Wang S; Chen ZY
    Int J Pharm; 2010 Nov; 400(1-2):194-200. PubMed ID: 20801205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of polymer architecture on surface properties, plasma protein adsorption, and cellular interactions of pegylated nanoparticles.
    Sant S; Poulin S; Hildgen P
    J Biomed Mater Res A; 2008 Dec; 87(4):885-95. PubMed ID: 18228249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.